Mesa Laboratories/MLAB

$106.62

4.26%
-
1D1W1MYTD1YMAX

About Mesa Laboratories

Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of life sciences tools and critical quality control solutions. Its segments include Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters.

Ticker

MLAB

Sector

Healthcare

Trading on

NASDAQ

Industry

Scientific & Technical Instr.

CEO

Gary Owens

Employees

698

Headquarters

Lakewood, United States

MLAB Metrics

BasicAdvanced
$551.6M
Market cap
583.88
P/E ratio
$0.18
EPS
0.83
Beta
$0.64
Dividend rate
0.63%
Dividend yield
$551.6M
0.82798
$178.64
$82.86
44.71K
$0.64
2.679
1.865
57.813
57.813
362.76%
26.275
0.26%
0.13%
0.24%
0.14%
583.876
2.591
1.369
14.799
0.28%
0.63%
0.63%
-4.27%
161.49%
23.01%
-17.47%

What the Analysts think about MLAB

Analyst Ratings

Majority rating from 3 analysts.
Buy

Price Targets

Average projection from 2 analysts.
21.93% upside
High $130.00
Low $130.00
$106.62
Current price
$130.00
Average price target

MLAB Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
3.93% profit margin
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$53.4M
0.56%
Net income
$2.1M
-275%
Profit margin
3.93%
-274.67%

MLAB Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 105.26%
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$0.11
-$0.10
-$0.23
$0.39
-
Expected
$0.37
-$0.02
$0.16
$0.19
-$0.12
Surprise
-70%
400%
-248.39%
105.26%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Mesa Laboratories stock?

Mesa Laboratories (MLAB) has a market cap of $551.6M as of April 25, 2024.

What is the P/E ratio for Mesa Laboratories stock?

The price to earnings (P/E) ratio for Mesa Laboratories (MLAB) stock is 583.88 as of April 25, 2024.

Does Mesa Laboratories stock pay dividends?

Yes, the Mesa Laboratories (MLAB) stock pays dividends to shareholders. As of April 25, 2024, the dividend rate is $0.64 and the yield is 0.63%. Mesa Laboratories has a payout ratio of 362.76% on a trailing twelve-month basis.

When is the next Mesa Laboratories dividend payment date?

The next Mesa Laboratories (MLAB) dividend payment is scheduled for June 14, 2024.

What is the beta indicator for Mesa Laboratories?

Mesa Laboratories (MLAB) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Mesa Laboratories stock price target?

The target price for Mesa Laboratories (MLAB) stock is $130, which is 24.44% above the current price of $104.47. This is an average based on projections from 2 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Mesa Laboratories stock

Buy or sell Mesa Laboratories stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing